Table 4. Association Between Sociodemographic and Clinical Variables and Fecal Elastase < 200 μg/g in Patients With Inflammatory Bowel Disease and Prevalence Ratios After Multiple Poisson Regression.
| n (%) | Prevalence, n (%) | 95% CI | PRa | 95% CIb | P-value | |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 21 (37%) | 4 (19%) | 1.72 - 36.38 | 1.26 | 0.39 - 4.06 | 0.7000 |
| Female | 35 (63%) | 6 (17%) | 4.26 - 30.02 | 1.00 | ||
| Disease | ||||||
| UCc | 30 (53.5%) | 5 (16.67%) | 2.91 - 30.43 | 1.00 | ||
| CDd | 26 (46.4%) | 5 (19.23%) | 3.60 - 34.86 | 1.25 | 0.22 - 7.19 | 0.8000 |
| Activity | ||||||
| Remission | 37 (66%) | 7 (18.92%) | 5.9 - 31.94 | 1.16 | 0.33 - 4.16 | 0.8000 |
| Active | 19 (33%) | 3 (15.79%) | 0.00 - 32.71 | 1.00 | ||
| IgG4 | ||||||
| > 140 mg/dL | 10 (17.8%) | 2 (20%) | 0.00 - 45.58 | 1.23 | 0.21 - 7.15 | 0.8000 |
| < 140 mg/dL | 46 (82.2%) | 8 (17.39%) | 6.09 - 28.69 | 1.00 | ||
| Azathioprine | ||||||
| No | 23 (41%) | 4 (17.39%) | 1.41 - 33.37 | 1 | ||
| Yes | 33 (59%) | 6 (21.21%) | 4.60 - 31.76 | 1.18 | 0.24 - 5.93 | 0.8000 |
| Corticosteroids | ||||||
| No | 25 (40%) | 5 (20%) | 3.82 - 36.18 | 1.00 | ||
| Yes | 31 (60%) | 5 (16.13%) | 2.77 - 29.49 | 1.04 | 0.23 - 4.73 | 0.9000 |
aPrevalence ratio (multiple Poisson regression). b95% confidence interval, corrected (multiple Poisson regression). cUlcerative colitis. dCrohn’s disease.